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Abstract
Introduction:  Pharyngocutaneous  ﬁstula  after  larynx  and  hypopharynx  cancer  surgery  can  cause
several damages.  This  study’s  aim  was  to  derive  a  clinical  decision  rule  to  predict  pharyngocu-
taneous ﬁstula  development  after  pharyngolaryngeal  cancer  surgery.
Methods:  A  retrospective  cohort  study  was  conducted,  including  all  patients  performing  total
laryngectomy/pharyngolaryngectomy  (n  =  171).  Association  between  pertinent  variables  and
pharyngocutaneous  ﬁstula  development  was  assessed  and  a  predictive  model  proposed.
Results: American  Society  of  Anesthesiologists  scale,  chemoradiotherapy,  and  tracheotomy
before surgery  were  associated  with  ﬁstula  in  the  univariate  analysis.  In  the  multivariate  analy-
sis, only  American  Society  of  Anesthesiologists  maintained  statistical  signiﬁcance.  Using  logistic
regression,  a  predictive  model  including  the  following  was  derived:  American  Society  of  Anes-
thesiologists,  alcohol,  chemoradiotherapy,  tracheotomy,  hemoglobin  and  albumin  pre-surgery,
local extension,  N-classiﬁcation,  and  diabetes  mellitus.  The  model’s  score  area  under  the  curve
was 0.76  (95%  CI  0.64--0.87).  The  high-risk  group  presented  speciﬁcity  of  93%,  positive  likelihood
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ratio  of  7.10,  and  positive  predictive  value  of  76%.  Including  the  medium-low,  medium-high,  and
high-risk groups,  a  sensitivity  of  92%,  negative  likelihood  ratio  of  0.25,  and  negative  predictive
value of  89%  were  observed.
Conclusion:  A  clinical  decision  rule  was  created  to  identify  patients  with  high  risk  of  pharyngo-
cutaneous  ﬁstula  development.  Prognostic  accuracy  measures  were  substantial.  Nevertheless,
it is  essential  to  conduct  larger  prospective  studies  for  validation  and  reﬁnement.
© 2015  Associac¸ão  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Cérvico-Facial.  Published  by
Elsevier Editora  Ltda.  All  rights  reserved.
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Derivac¸ão  de  uma  regra  de  decisão  clínica  para  predic¸ão de  desenvolvimento  de
fístula  faringocutânea  pós  laringectomia
Resumo
Introduc¸ão: Fístula  faringocutânea  após  cirurgia  de  câncer  de  laringe  e  hipofaringe  causa  diver-
sos danos.  Nosso  objetivo  foi  derivar  uma  regra  de  decisão  clínica  (RDC)  para  predizer  o
desenvolvimento  da  fístula  faringocutânea  após  cirurgia.
Método:  Estudo  de  coorte  retrospectivo  incluindo  todos  os  pacientes  submetidos  à  laringec-
tomia total  e  faringolaringectomia  (n  =  171).  Analisou-se  a  associac¸ão  entre  as  variáveis
pertinentes  e  o  desenvolvimento  da  fístula  e  foi  proposto  um  modelo  preditivo.
Resultados:  Na  análise  univariada,  a  ASA,  quimioradioterapia  (QRT)  e  traqueostomia  antes  da
cirurgia foram  associadas  à  fístula.  Na  análise  multivariada,  somente  a  ASA  manteve-se  estatis-
ticamente  signiﬁcante.  Por  regressão  logística,  derivamos  um  modelo  preditivo  incluindo:  ASA,
álcool, QRT,  traqueostomia,  hemoglobina  e  albumina  pré-operatórias,  extensão  local,  N,  DM.
A curva  ROC  do  modelo  foi  0,76  (95%  CI  0,64--0,87).  O  grupo  de  alto  risco  teve  especiﬁcidade
93%, Likelihood  positivo  7,10  e  valor  preditivo  positivo  76%.  Incluindo  os  grupos  de  médio  baixo,
médio alto  e  alto  risco,  temos  sensibilidade  de  92%,  Likelihood  negativo  0,25  e  valor  preditivo
positivo  89%.
Conclusão:  Criamos  uma  RDC  para  identiﬁcar  os  pacientes  de  alto  risco  ao  desenvolvimento  da
fístula faringocutânea.  As  medidas  de  acurácia  prognóstica  foram  substanciais.  Entretanto,  é
essencial  conduzir  estudos  prospectivos  maiores  para  validac¸ão/reﬁnamento  do  modelo.
© 2015  Associac¸ão  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Cérvico-Facial.  Publicado  por
Elsevier Editora  Ltda.  Todos  os  direitos  reservados.
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Larynx  and  hypopharynx  cancer  represents  almost  45%  of  all
treated  diseases  in  this  tertiary  care  hospital’s  department
of  otolaryngology,  specialized  in  oncology.
Prevalence  of  pharyngocutaneous  ﬁstula  after  larynx  and
pharyngolarynx  cancer  surgery  is  reported  to  be  between  9%
and  25%.1,2 Its  occurrence  vastly  increases  these  patients’
length  of  stay  and  consequently  the  treatment  cost.3 More-
over,  its  occurrence  can  cause,  among  other  physical  and
psychological  damages,  the  delay  in  onset  of  comple-
mentary  therapies  (such  as  radiotherapy/chemotherapy),
consequently  delaying  recovery.
Until  now,  no  study  has  proposed  a  clinical  decision  rule
(CDR)  for  predicting  pharyngocutaneous  ﬁstula  after  total
laryngectomy  and  primary  or  rescue  pharyngolaryngectomy,
with  or  without  neck  dissection,  and  major  predictive  fac-
tors  were  scarcely  assessed.4 Thus,  the  goal  was  to  derive
such  a  CDR  in  a  sample  of  patients  from  this  hospital.  Its
creation  is  intended  to  encourage  clinical  behavior  modi-
ﬁcation  in  order  to  avoid  development  of  this  complication
and  thus  facilitate  the  reduction  of  unnecessary  costs  as  well
as  improve  patients’  quality  of  life.
D
A
tethods
 retrospective  cohort  study  was  conducted  (longitudinal
istorical  cohort  study),  consecutively  including  all  the
atients  performing  total  laryngectomy/pharyngolarynge-
tomy,  due  to  cancer  of  the  larynx  and  hypopharynx,  in  the
tolaryngology  Department  of  this  hospital,  from  February
f  2006  to  June  of  2011.  All  patients  diagnosed  with  laryn-
eal  and  pharyngolaryngeal  cancer  were  evaluated  by  the
eam  before  ﬁnal  treatment.  Only  procedures  consistent
ith  total  laryngectomy  with  or  without  partial  pharyngec-
omy  and  primary  closure  of  the  pharyngeal  defect  were
onsidered  in  this  study.  The  operations  were  performed
y  four  different  surgeons,  two  with  ten  or  more  years  of
xperience,  and  two  with  less.
This  study  conduction  was  approved  by  the  Ethics  Com-
ittee  of  this  hospital.
ata  collectionll  variables  and  outcome  occurrence  were  collected  by
he  principal  investigator  (SC),  between  August  of  2011  and
396  
Table  1  American  Society  of  Anesthesiologists  risk  classi-
ﬁcation  system.
ASA  class  Class  deﬁnition
I  Normal  healthy  patient
II  Patient  with  mild  systemic  disease
III Patient  with  systemic  disease  that  is  not
incapacitating
IV  Patient  with  an  incapacitating  systemic  disease
that  is  a  constant  threat  to  life
V A  moribund  patient  who  is  not  expected  to
survive  for  24  hours  with  or  without  operation
Source:  Amir Qaseem, Vincenza Snow; Nick Fitterman; E. Rodney
Hornbake; Valerie A. Lawrence; Gerald W. Smetana; Kevin Weiss,
Douglas K. Owens; Clinical Efﬁcacy Assessment Subcommittee
of the American College of Physicians; Risk Assessment for and
Strategies To Reduce Perioperative Pulmonary Complications
for Patients Undergoing Noncardiothoracic. Surgery: A Guide-
line from the American College of Physicians. Annals of Internal
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which  had  potential  for  inclusion  in  the  predictive  model
being  developed,  as  already  explained  (Table  3).Medicine. 2006 Apr;144(8):575--580.
anuary  of  2012,  using  the  institutional  medical  records.
ollow-up  was  performed  until  the  patients  were  dis-
harged.
A  systematic  review  was  conducted  in  order  to  identify  all
he  predictive  risk  factors  for  the  pharyngocutaneous  ﬁstula
evelopment  described  in  the  available  literature  (results
ot  reported  in  this  article).4
All  the  variables  considered  as  pertinent  in  this  review
ere  collected,  namely:
a)  Factors  related  to  the  patient:  American  Society  of
Anesthesiologists  (ASA)  classiﬁcation  (Table  1),  alcohol
consumption  (considered  heavy  if  the  patient  regularly
drank  over  1  L  of  alcoholic  beverage  per  day,  consid-
ered  ex-consumers  or  light  consumers  if  they  drank
from  zero  to  four  cups/day),  pre-operative  hemoglobin
level  (<12.4  g/dL  or  ≥12.4  g/dL),  pre-operative  albumin
value  (<37  g/L  or  ≥37  g/L),  and  presence  of  major  co-
morbidities  (diabetes  mellitus  (DM),  chronic  obstructive
pulmonary  diseases  (COPD),  heart  disease,  or  liver  dis-
ease).
b)  Factors  related  to  illness:  N-classiﬁcation  (based  on
the  AJCC  Cancer  Staging  Manual,  2010  --  7th  edition),
surgical  intervention  performed  (total  laryngectomy  or
pharyngolaryngectomy).
c)  Factors  related  to  treatment:  radiotherapy  only  (Rt)
or  chemoradiotherapy  (CRT)  prior  to  surgery  and  tra-
cheotomy  prior  to  operation.
Nutritional  deﬁciency  and  loss  of  weight  were  previously
xcluded  from  the  analysis  because  insufﬁcient  data  were
vailable  in  the  medical  records  assessed  (120  missing).
Regarding  outcome,  pharyngocutaneous  ﬁstula  develop-
ent  was  conﬁrmed  clinically  in  postoperative  daily  visits
y  more  than  one  observer  (surgeon  and  resident)  with  the
tterance  content  of  saliva  and  the  path  the  ﬁstulous  wound
nalysis. fCecatto  SB  et  al.
tatistical  analysis
ll  variables  were  categorical  and  their  presence  in  each
roup  (with  or  without  outcome  development)  was  com-
ared  using  the  chi-squared  or  Fisher’s  exact  test,  when
pplicable.  Signiﬁcance  was  considered  as  a  p-value  <  0.05.
The  inclusion  of  ten  to  ﬁfteen  subjects  per  assessed
redictive  variable  is  recommended.5 As  the  present  study
nalyzed  the  association  between  13  variables  and  an  out-
ome,  at  least  130  subjects  were  required.
It  is  common  to  observe  that,  when  conducting  mul-
ivariate  analysis,  there  is  a  change  in  several  predictive
ariables’  signiﬁcance  level.  Thus,  in  several  studies,5--7
ariables  have  been  included  in  the  multivariate  analysis
hen  a  p-value  <  0.2  is  observed  in  the  univariate  analysis.
n  this  manner,  it  is  assured  that  all  pertinent  and  poten-
ially  predictive  variables  are  studied.  The  same  criterion
as  used  for  detecting  which  variables  should  be  included
n  this  study’s  derived  model.
Multivariate  analysis,  using  logistic  regression,  was  con-
ucted  for  the  predictive  model’s  derivation.
After  the  predictive  model  was  created,  the  area  under
he  receiver  operating  characteristic  curve  (AUC)  was  cal-
ulated  and,  through  the  ‘‘best  ﬁt’’  of  the  coordinates  of
he  curve,  four  risk  categories  were  created:  high  risk  (4),
edium-high  risk  (3),  medium-low  risk  (2),  and  low  risk
1).  The  sensitivity,  speciﬁcity,  predictive  values,  and  like-
ihood  ratios  with  95%  conﬁdence  intervals  (95%  CI)  were
alculated.  All  statistical  analysis  was  performed  using  SPSS
ersion  18.0.
esults
his  study  included  171  subjects,  characterized  in  Table  2.
All  the  participants  were  M0  and  pharyngeal  closure  was
erformed  with  two  layers  (muscles  and  mucosa)  of  contin-
ous  suture  or  stapler  (used  whenever  possible).
During  a  mean  follow-up  of  30  days,  48  subjects  (28.1%)
eveloped  pharyngocutaneous  ﬁstula  postoperatively.  They
ere  all  classiﬁed  as  ASA  2 or  3;  79.2%  as  high  alcohol  con-
umers,  almost  48.9%  had  preoperative  hemoglobin  level
elow  12.5  g/dL,  16.7%  were  diabetic  patients,  6.2%  had
ome  degree  of  COPD,  22.9%  showed  impaired  liver  function
r  some  degree  of  heart  disease,  8.3%  had  received  radio-
herapy  previously  to  the  operation,  18.8%  had  undergone
hemotherapy/radiotherapy  prior  to  the  operation,  and  in
8.3%  an  emergency  tracheotomy  before  elective  surgery
as  required.  In  fact,  45%  were  performed  emergently  and
3.3%  were  elective  tracheotomies.
It  was  observed  that  patients  with  advanced  stage  (IVa
nd  IVb)  had  the  largest  absolute  number  of  pharyngocu-
aneous  ﬁstula  (n  =  40)  observed  in  the  sample,  although  it
as  not  statistically  signiﬁcant  (p  =  0.25).  However,  the  87
emaining  patients  in  these  stages  (representing  almost  50%
f  the  sample)  did  not  develop  a  ﬁstula.  Univariate  and  mul-
ivariate  analysis  was  performed  with  the  inclusion  of  the
elevant  factors  obtained  by  a  previous  systematic  review,4It  was  found  that  ASA  2  and  3,  prior  CRT,  tracheotomy  per-
ormed  before  surgery,  and  low  levels  of  hemoglobin  were
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Table  2  Characterization  of  the  sample  according  to  TNM
stage (AJCC  Cancer  Staging  Manual,  2010  --  7th  edition)  and
demographic  features.
Characteristic  Frequency
(n  =  171)
%
Demographic  features
Male  gender  166  97.1
Age (>60  years)  75  43.9
Smoking  habits  (>20  cigarettes/day)  142  83
Stage
I 1  0.6
II 5  2.9
III 38  22.2
IVa 120  70.2
IVb 7  4.1
T
Tis 1  0.6
T1 1  0.6
T2 5  2.9
T3 45  26.3
T4a 119  69.6
N
N0 83  48.5
N1 25  14.6
N2a 28  16.4
N2b 17  9.9
N2c 13  7.6
a
t
v
<
l
a
p
s
a
e
b
f
R
aN3 5  2.9
associated  with  ﬁstula  development  in  the  univariate  anal-
ysis.  In  the  multivariate  analysis,  only  the  ASA  classiﬁcation
maintained  statistical  signiﬁcance  (p  <  0.05).  Albumin,  prior
CRT,  and  tracheotomy  performed  before  surgery  showed
predictive  potential  (p  <  0.2)  for  inclusion  in  the  model.
Although  albumin  did  not  achieve  statistical  signiﬁcance
in  the  univariate  analysis  and  there  were  many  missing
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Figure  1  Model’s  area  under  the  receiver  operating  charac-
teristic  curve.  Ivory  line,  line  of  reference  of  AUC  0.5;  blue  line,
score of  the  model;  green  line,  four  categories  of  the  model.
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lbumin  values  in  this  sample  (85  missing),  it  was  observed
hat  its  exclusion  from  the  model  substantially  reduced  the
alidity  (particularly  regarding  sensitivity).
Alcohol  consumption,  preoperative  hemoglobin
 12.5  g/dL,  DM  presence,  N-classiﬁcation,  primary  tumor
ocation  and  extension,  and  no  prior  Rt  were  not  associ-
ted  with  ﬁstula  development,  but  increased  the  CDR’s
rognostic  accuracy  (regarding  the  balance  of  sensitivity-
peciﬁcity)  and  thus  were  also  included.
The  model  therefore  included  all  pre-operative  variables
nalyzed  that  presented  a  p-value  <  0.2  and  all  those  consid-
red  important  by  a  systematic  review  previously  conducted
y  this  team.4 The  best  results  were  obtained  using  the
ollowing  model:
isk  score  =  (4.98  ×  ASA  classiﬁcation)
+  (1.97  ×  alcohol  consumption)
+  (5.10  ×  chemoradiotherapy)
+ (2.40  ×  tracheotomy)
+ (0.75  ×  hemoglobin  pre-surgery)
+  (0.69  ×  local  extension)
+  (1.01  ×  N-classiﬁcation)
+ (0.75  ×  presence  of  DM)
+  (3.03  ×  albumin  pre-surgery).
This  model  presented  an  AUC  of  0.74  (95%  CI  0.61--0.86),
s  shown  in  Fig.  1.
The  model’s  score  stratiﬁcation  into  four  different  risk
ategories  is  proposed:  low  risk  (for  a  score  ≤9.88),  medium-
ow  (9.881--12.25),  medium-high  (12.26--17.1),  and  high  risk
score  >17.1).  This  stratiﬁcation  resulted  in  the  prognostic
ccuracy  values  in  Table  4.  The  values  for  the  cut-offs  were
elected  by  an  assessment  of  AUC  coordinates,  using  those
hat  provided  best  ﬁt.
Approximately  half  of  the  participants  (48%)  who
eveloped  a  pharyngocutaneous  ﬁstula  were  classiﬁed  as
igh  risk.  By  associating  the  three  highest  risk  groups
high  +  medium-high  +  medium-low),  92%  of  ﬁstula  develop-
ent  was  predicted.  It  was  also  observed  that  with  an
ncrease  in  the  risk  degree,  more  subjects  develop  ﬁstula
p  <  0.001  for  chi-squared  in  an  association  and  trend  analy-
is).
A  high  speciﬁcity  for  the  high-risk  group  (93%)  was  noted,
ith  moderately  high  positive  likelihood  ratio  (LR+)  of  (7.10)
nd  positive  (PPV)  and  negative  predictive  values  (NPV)  with
igh  results  (76%  and  79%  respectively)  (Table  5).  With  the
hree  groups  of  medium-low/medium-high/high  risk,  a  sen-
itivity  of  92%,  negative  likelihood  ratio  (LR-)  of  0.25,  and
PV  of  89%  were  obtained.
The  measures  of  prognostic  validity  for  ASA  classiﬁcationere  also  calculated,  in  order  to  compare  with  the  results  of
arwell  et  al.8;  these  values  are  shown  in  Table  6.  Thus,  this
erived  model  is  statistically  superior  to  ASA  classiﬁcation
hen  compared  the  measures  of  prognostic  validity.
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Table  3  Univariate  and  multivariate  analysis  of  the  relationship  between  the  variables  included  in  the  clinical  decision  rule
and the  frequency  of  pharyngocutaneous  ﬁstula.
Variables  All
n  (%)
With  ﬁstula
n  (%)
Without  ﬁstula
n  (%)
Univariate  analysis
p-Value
Multivariate  analysis
p-Value
ASA
2  107  (63)  25  (51.1)  82  (68) 0.05a 0.005
3 62  (36.2)  23  (48.9)  39  (32)
Alcohol
Heavy 126  (73.7)  38  (79.2)  88  (71.5)  0.34a 0.361
Hemoglobin  pre
<12.4  g/dL 65  (39.6) 22  (48.9) 43  (36.1)  0.15a 0.665
Albumin pre
<37.0  g/L 30  (34.1) 7  (25) 23  (38.3) 0.24a 0.07
Co morbidities
DM  25  (14.6)  8  (16.7)  17  (13.8)  0.63a 0.72
COPD 18  (10.5)  3  (6.2)  15  (12.2)  0.4a
Liver  disease  39  (22.8)  11  (22.9)  28  (22.8)  1a
Cardiopathy  42  (24.6)  11  (22.9)  31  (25.2)  0.85a
N
N0  83  (48.6)  21  (43.8)  62  (50.4) 0.25b 0.933
N1 25  (14.6)  8  (16.7)  17  (13.8)
N2a +  N2b  +  N2c  58  (33.9)  17  (9.94)  41  (23.96)
N3 5  (2.9)  2  (1.16)  3  (1.74)
Location
Larynx 67  (39.2)  18  (10.5)  49  (28.6) 0.86a 0.539
Pharyngolaryngeal  104  (60.8)  30  (62.5)  74  (60.2)
Rt pre
Yes  12  (7.0)  4  (8.3)  8  (6.5)  0.74a
CRT  pre
Yes  15  (8.8)  9  (18.8)  6  (4.9)  0.01a 0.120
Tracheotomy  pre
Yes 77  (45)  28  (58.3)  49  (39.8)  0.04a 0.144
Rt, radiotherapy; CRT, chemoradiotherapy; pre, preoperative; DM, diabetes mellitus; COPD, chronic obstructive pulmonary diseases.
a Fisher’s exact test.
b Chi-squared test.
Table  4  Risk  stratiﬁcation  of  developing  ﬁstula  pharyngocutaneous  for  the  model.
Pharyngocutaneous  ﬁstula  Risk  groups  Total
Low  risk  Medium-low  risk  Medium-high  risk  High  risk
No  17  (89%)  16  (80%)  22  (73%)  4  (24%)  59
Yes 2  (11%)  4  (20%)  8  (27%)  13  (76%)  27
Total 19  20  30  17  86
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aiscussion
linical  decision  rules  (CDR)  are  instruments  used  to
ncrease  health  professionals’  accuracy  in  diagnostic  and
rognostic  assessment  by  summarizing  the  probability  of  a
articular  outcome.
Pharyngocutaneous  ﬁstula  represents  a  major  postopera-
ive  complication  of  laryngectomized  patients.  Until  now,
o  CDR  has  been  derived  for  determining  the  risk  of  ﬁs-
ula  development;  consequently,  this  study  was  conducted.
s  13  variables  were  included,  the  inclusion  of  130  to  195
articipants  was  required.  The  present  study  included  171
ﬁ
o
(atients,  which  should  be  an  adequate  number.5 It  was
ecided  to  use  four  categories  in  order  to  maintain  equi-
ibrium  between  the  best  ﬁt  of  the  model  and  clinical
pplication;  i.e.,  on  one  hand,  with  a  higher  number  of
ategories,  the  classiﬁcation  can  be  adjusted  more  effec-
ively  to  the  original  score’s  AUC;  on  the  other  hand,  clinical
pplicability  improves  with  a  lower  number  of  categories.
In  this  analysis,  the  incidence  of  the  pharyngocutaneous
stula  was  28.1%,  which  is  between  the  values  obtained  by
ther  authors.9--14
For  most  authors,  the  male  gender  was  more  represented
in  the  present  sample,  97.1%),  and  ﬁstula  developed  around
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he  10th  to  the  15th  postoperative  day,  as  demonstrated  in
8%  of  the  present  cases.1,15--23
This  analysis  has  shown,  in  agreement  with  other
tudies,17,24,25 that  for  the  advanced  stage  (IVa  and  IVb)  there
eems  to  be  a  higher  ﬁstula  incidence.  This  relationship  was
ot  statistically  signiﬁcant  both  in  the  present  as  well  as  in
ther  studies.1,10--13,15,16,18--23,26--29
The  univariate  analysis  conﬁrmed  that  CRT  and  prior  tra-
heotomy  are  factors  associated  with  formation  of  pharyn-
ocutaneous  ﬁstula,  as  did  other  authors.9,12,13,24,26,30,31
racheotomy  previous  to  the  operation  was  not  con-
idered  a  risk  factor  for  the  ﬁstulization  by  several
uthors15,18,20--22,25--28,31 contrary  to  the  present  ﬁndings.
n  performing  the  multivariate  analysis,  these  variables
emained  as  potential  predictive  factors  for  the  ﬁstula
evelopment,  as  other  authors  have  concluded.24,30
In  the  univariate  analysis,  radiotherapy  prior  to  surgery
as  not  signiﬁcant  for  pharyngocutaneous  ﬁstula  develop-
ent,  as  other  authors  concluded.2,11,14,18,20,21,25--29,32,33 Their
nclusion  in  the  ﬁnal  model  did  not  add  signiﬁcant  changes
n  accuracy,  thus  they  were  excluded.
ASA  classiﬁcation,  unlike  other  studies,8,21,34 was  signiﬁ-
ant  as  a  risk  factor  for  ﬁstula  development  in  the  univariate
nd  multivariate  analysis,  which  demonstrates  that  the  pres-
nce  of  pre-operative  co-morbidities  and  functional  status
f  the  patient  have  a  major  importance  in  the  development
f  intra-  and  post-surgical  complications.
Few  authors  have  assessed  the  ASA  classiﬁcation’s  pre-
ictive  value8 for  this  outcome,  although  its  relevance
as  been  demonstrated  in  the  present  sample,  reﬂecting
he  key  role  of  the  pre-operative  control  of  comorbidi-
ies.  Paradoxically,  evaluating  each  comorbidity  separately
DM,  COPD,  liver  disease,  and  heart  disease),  they  did  not
emonstrate  signiﬁcant  association  with  ﬁstula  develop-
ent  (both  in  the  univariate  and  multivariate  analysis).
n  this  aspect,  the  available  evidence  is  contradictory,  as
ome  authors  reported  the  same  results11,13 while  others
ound  a  signiﬁcant  relationship  between  ﬁstula  and  these
omorbidities.1,12,15,16,20,21,34
After  the  multivariate  analysis,  pre-operative  hypoal-
umin  (<3.7  g/L)  was  an  independent  factor  for  the
evelopment  of  the  pharyngocutaneous  ﬁstula,  as  other
uthors  concluded.12,15,20,34
In  the  available  literature,  it  was  not  possible  to  ﬁnd  a
DR  developed  speciﬁcally  for  stratifying  patients  by  their
isk  of  pharyngocutaneous  ﬁstula  formation  after  pharyngo-
aryngectomy  and  total  laryngectomy.
For  the  high-risk  group,  a  high  speciﬁcity  was  observed,
nd  therefore  the  ability  to  determine  among  patients  at
ighest  risk  those  who  will  not  develop  pharyngocutaneous
stula.  However,  the  model  identiﬁed  with  high  sensitivity
he  groups  of  medium-low  +  medium-high  +  highrisk  subjects
ho  will  develop  a  ﬁstula.  In  a hospital  setting,  this  allows
he  distribution  of  economic  and  personnel  resources  pri-
arily  to  patients  with  higher  probability  for  the  occurrence
f  postoperative  complications.  It  also  allows  healthcare
rofessionals  to  act  more  intensively  and  earlier  in  the  pre-
perative  and  post-operative  period  in  order  to  assist  the
dentiﬁed  the  risk  group.
The  terrible  consequences  for  the  patient’s  quality  of
ife  and  prognosis  after  development  of  pharyngocutaneous
stula  are  well-known.  Moreover,  the  economic  resources
400  Cecatto  SB  et  al.
Table  6  Risk  stratiﬁcation  of  the  American  Society  of  Anesthesiologists  classiﬁcation  and  precision  measurements.
ASA  Fistula
n  (%)
Se  %
(95%  CI)
Spec  %
(95%  CI)
LR+
(95%  CI)
LR−
(95%  CI)
PPV  %
(95%  CI)
NPV  %
(95%  CI)
ASA  3  23  (48.9)  47  (33--62)  67  (59--76)  1.48  (1--2.2)  0.76  (0.57--.03)  37  (25--49)  76  (68--84)
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1Se, sensitivity; Spec, speciﬁcity; LR+, positive likelihood; LR−,  ne
tive value; 95% CI, 95% conﬁdence interval.
argeted  to  the  healing  this  complication  are  a  tremendous
nancial  burden  on  any  healthcare  system.
It  should  be  emphasized  that  the  derived  model  has
ome  limitations.  The  collection  of  the  variables  was  per-
ormed  retrospectively  and  therefore  was  not  as  complete
nd  accurate  as  it  would  have  been  with  a  prospective  basis.
xamples  include  the  absence  of  albumin  in  the  preopera-
ive  records  of  85  patients  and  the  lack  of  observed  records
o  characterize  the  nutritional  status  of  the  patient  prior
o  surgery.  Regardless  of  the  limiting  factors,  a  CDR  has
een  developed  for  easy  application  with  robust  values  for
rognostic  accuracy,  namely  the  AUC  value  of  0.76  (95%  CI
.64--0.87).
inal considerations
e  have  statistically  calculated  a  mathematical  model  with
 good  accuracy  to  detect  the  groups  with  medium/high
isk  of  pharyngocutaneous  ﬁstula  development.  Ulteriorly,
t  will  allow  a  best  distribution  of  economic  and  personal
esources  targeting  to  patients  with  higher  probability  of
his  complication  occurrence.  These  study’  major  strengths
re  the  fact  that  it  represents  ﬁrst  adequate  and  speciﬁcally
DR  derived  for  the  pharyngocutaneous  ﬁstula  development
isk  stratiﬁcation  that  additionally  presented  robust  values
f  prognostic  validity.  The  major  limitations  of  the  study  are
ts  retrospective  and  unicenter  design  and  a  modest  sample
ize.  Despite  these  limitations  our  CDR  outperformed  the
SA  classiﬁcation  --  which  was  validated  for  this  outcome
rediction.
This  CDR  is  presented  as  a  proposal  for  a  later  prospective
ulticenter  validation,  reliability  assessment  and  optimiza-
ion.  We  also  wish  to  assess  their  applicability  practice
mong  health  professionals  and  therefore  make  an  economic
mpact  and  ease  of  use  analysis  of  implementation  among
ealth  services  in  our  country.
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